Skip to main navigation Skip to search Skip to main content

A Randomized, Double-blind Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Participants with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease

Project: Research

Project Details

StatusActive
Effective start/end date04/7/23 → 04/30/27

Funding

  • Sage Therapeutics Incorporated: $171,751.00